Conneqt Health Limited
CQTHF
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 248.97% | 113.57% | 5.17% | -12.69% | -29.54% |
| Total Other Revenue | 74.86% | 62.43% | 50.45% | 47.41% | 40.41% |
| Total Revenue | 215.05% | 105.06% | 11.58% | -5.26% | -21.97% |
| Cost of Revenue | 6.52% | -6.82% | -16.44% | -21.16% | -26.47% |
| Gross Profit | 265.15% | 133.67% | 19.14% | -1.05% | -20.81% |
| SG&A Expenses | -5.93% | 1.96% | 12.52% | 32.71% | 41.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.78% | 3.81% | 16.47% | 23.64% | 30.56% |
| Operating Income | 67.72% | 29.71% | -18.40% | -37.29% | -60.95% |
| Income Before Tax | 33.89% | -3.64% | -48.31% | -43.25% | -35.88% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 33.89% | -3.64% | -48.31% | -43.25% | -35.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 33.89% | -3.64% | -48.31% | -43.25% | -35.88% |
| EBIT | 67.72% | 29.71% | -18.40% | -37.29% | -60.95% |
| EBITDA | 67.98% | 29.63% | -19.15% | -38.69% | -62.59% |
| EPS Basic | 44.89% | 15.12% | -16.03% | -14.11% | -10.80% |
| Normalized Basic EPS | 46.50% | 16.44% | -14.80% | -11.55% | -6.86% |
| EPS Diluted | 45.28% | 15.72% | -15.21% | -14.05% | -11.60% |
| Normalized Diluted EPS | 46.50% | 16.44% | -14.80% | -11.55% | -6.86% |
| Average Basic Shares Outstanding | 23.04% | 24.59% | 26.31% | 24.47% | 22.46% |
| Average Diluted Shares Outstanding | 23.04% | 24.59% | 26.31% | 24.47% | 22.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |